These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30132166)

  • 1. UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.
    Garner EF; Stafman LL; Williams AP; Aye JM; Goolsby C; Atigadda VR; Moore BP; Nan L; Stewart JE; Hjelmeland AB; Friedman GK; Beierle EA
    J Neurooncol; 2018 Nov; 140(2):209-224. PubMed ID: 30132166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro.
    Williams AP; Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
    J Surg Res; 2018 Aug; 228():54-62. PubMed ID: 29907230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts.
    Garner EF; Williams AP; Stafman LL; Aye JM; Mroczek-Musulman E; Moore BP; Stewart JE; Friedman GK; Beierle EA
    Sci Rep; 2018 May; 8(1):6913. PubMed ID: 29720672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts.
    Marayati R; Bownes LV; Stafman LL; Williams AP; Quinn CH; Atigadda V; Aye JM; Stewart JE; Yoon KJ; Beierle EA
    Transl Oncol; 2021 Jan; 14(1):100893. PubMed ID: 33010553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic Malignancies.
    Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
    Mol Cancer Ther; 2016 May; 15(5):911-21. PubMed ID: 26873726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis.
    Chou CF; Hsieh YH; Grubbs CJ; Atigadda VR; Mobley JA; Dummer R; Muccio DD; Eto I; Elmets CA; Garvey WT; Chang PL
    J Dermatol Sci; 2018 Jun; 90(3):343-356. PubMed ID: 29599065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.
    Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
    Mol Cancer Ther; 2015 Jul; 14(7):1559-69. PubMed ID: 25944918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src is a novel potential off-target of RXR agonists, 9-cis-UAB30 and Targretin, in human breast cancer cells.
    Kim MS; Lim DY; Kim JE; Chen H; Lubet RA; Dong Z; Bode AM
    Mol Carcinog; 2015 Dec; 54(12):1596-604. PubMed ID: 25328014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of KLF4-mediated tumor initiation and malignant transformation by UAB30 rexinoid.
    Jiang W; Deng W; Bailey SK; Nail CD; Frost AR; Brouillette WJ; Muccio DD; Grubbs CJ; Ruppert JM; Lobo-Ruppert SM
    Cancer Biol Ther; 2009 Feb; 8(3):289-98. PubMed ID: 19197145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts.
    Williams AP; Garner EF; Stafman LL; Aye JM; Quinn CH; Marayati R; Stewart JE; Atigadda VR; Mroczek-Musulman E; Moore BP; Beierle EA; Friedman GK
    Transl Oncol; 2019 Oct; 12(10):1364-1374. PubMed ID: 31362265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on gene expression in rat liver after administration of RXR agonists: UAB30, 4-methyl-UAB30, and Targretin (Bexarotene).
    Vedell PT; Lu Y; Grubbs CJ; Yin Y; Jiang H; Bland KI; Muccio DD; Cvetkovic D; You M; Lubet R
    Mol Pharmacol; 2013 Mar; 83(3):698-708. PubMed ID: 23292798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma.
    Marayati R; Williams AP; Bownes LV; Quinn CH; Stewart JE; Mroczek-Musulman E; Atigadda VR; Beierle EA
    J Pediatr Surg; 2020 Jun; 55(6):1072-1080. PubMed ID: 32164984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoid X Receptor Agonists Upregulate Genes Responsible for the Biosynthesis of All-Trans-Retinoic Acid in Human Epidermis.
    Wu L; Chaudhary SC; Atigadda VR; Belyaeva OV; Harville SR; Elmets CA; Muccio DD; Athar M; Kedishvili NY
    PLoS One; 2016; 11(4):e0153556. PubMed ID: 27078158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine oncogenicity and pharmacokinetics studies of 9-cis-UAB30, an RXR agonist, for breast cancer chemoprevention.
    Kapetanovic IM; Horn TL; Johnson WD; Cwik MJ; Detrisac CJ; McCormick DL
    Int J Toxicol; 2010; 29(2):157-64. PubMed ID: 20335511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel second-generation rexinoid induces growth arrest and reduces cancer cell stemness in human neuroblastoma patient-derived xenografts.
    Marayati R; Bownes LV; Quinn CH; Wadhwani N; Williams AP; Markert HR; Atigadda V; Aye JM; Stewart JE; Yoon KJ; Beierle EA
    J Pediatr Surg; 2021 Jun; 56(6):1165-1173. PubMed ID: 33762121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of CEP-751 (KT-6587) on human neuroblastoma and medulloblastoma xenografts.
    Evans AE; Kisselbach KD; Yamashiro DJ; Ikegaki N; Camoratto AM; Dionne CA; Brodeur GM
    Clin Cancer Res; 1999 Nov; 5(11):3594-602. PubMed ID: 10589776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts.
    Shu Q; Antalffy B; Su JM; Adesina A; Ou CN; Pietsch T; Blaney SM; Lau CC; Li XN
    Clin Cancer Res; 2006 Aug; 12(15):4687-94. PubMed ID: 16899619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-trans-retinoic acid induces cell growth arrest in a human medulloblastoma cell line.
    Chang Q; Chen Z; You J; McNutt MA; Zhang T; Han Z; Zhang X; Gong E; Gu J
    J Neurooncol; 2007 Sep; 84(3):263-7. PubMed ID: 17453147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.
    Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern CP; Kogner P
    Med Pediatr Oncol; 2001 Jan; 36(1):127-31. PubMed ID: 11464864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma.
    Spiller SE; Ravanpay AC; Hahn AW; Olson JM
    J Neurooncol; 2006 Sep; 79(3):259-70. PubMed ID: 16645722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.